5-(BIPHENYL-4-YL)-3-PHENYL-1,2,4-OXADIAZOLYL DERIVATIVES AS LIGANDS ON THE SPHINGOSINE 1-PHOSPHATE(SIP)RECEPTORS
申请人:Bombrun Agnes
公开号:US20130116289A1
公开(公告)日:2013-05-09
The present invention provides compounds of Formula (I), as selective S1P1 inhibitors, as well as their use for treating multiple sclerosis and other diseases.
本发明提供了式(I)的化合物,作为选择性S1P1抑制剂,以及它们用于治疗多发性硬化症和其他疾病的用途。